Variant Gene Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs671
rs671
0.850 GeneticVariation BEFREE We genotyped rs671 of ALDH2 in 96 coronary heart disease (CHD) patients with four methods including high resolution melting analysis (HRM), TaqMan allelic discrimination assay (TaqMan), allele-specific PCR (AS-PCR) and pyrosequencing. 25803854

2016

dbSNP: rs671
rs671
0.850 GeneticVariation BEFREE The Glu504Lys polymorphism of aldehyde dehydrogenase 2 contributes to development of coronary artery disease. 25263942

2015

dbSNP: rs671
rs671
0.850 GeneticVariation BEFREE The association between the aldehyde dehydrogenase 2 (ALDH2, rs671) genotypes and the estimated glomerular filtration rate (eGFR) was investigated in Japanese hypertensive patients with/without coronary artery disease or with ischemic heart failure (HF), and age/sex-matched normotensive healthy controls. 24067347

2015

dbSNP: rs671
rs671
0.850 GeneticVariation BEFREE ALDH2 rs671 Polymorphism and coronary heart disease risk among Asian populations: a meta-analysis and meta-regression. 23697560

2013

dbSNP: rs671
rs671
0.850 GeneticVariation GWASCAT Genome-wide association study of coronary artery disease in the Japanese. 21971053

2012

dbSNP: rs671
rs671
0.850 GeneticVariation GWASDB Genome-wide association study of coronary artery disease in the Japanese. 21971053

2012

dbSNP: rs671
rs671
0.850 GeneticVariation BEFREE The ALDH2 Glu504Lys polymorphism is associated with coronary artery disease in Han Chinese: Relation with endothelial ADMA levels. 20417517

2010

dbSNP: rs1333049
rs1333049
0.840 GeneticVariation BEFREE Our study aims to explore the association of rs7025486 single-nucleotide polymorphisms (SNP) in DAB2IP and rs1333049 on chromosome 9p21.3 with the coronary artery disease in Chinese population. 28962556

2018

dbSNP: rs10455872
rs10455872
LPA
0.840 GeneticVariation GWASCAT Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib. 28753643

2017

dbSNP: rs1333049
rs1333049
0.840 GeneticVariation BEFREE Despite excellent power, the 9p21 locus SNP (rs1333049) was only modestly associated with MI (HR = 1.09, p-value = 0.02) and marginally with CHD (HR = 1.06, p-value = 0.08). 26950853

2016

dbSNP: rs1333049
rs1333049
0.840 GeneticVariation GWASCAT Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases. 27790247

2016

dbSNP: rs10455872
rs10455872
LPA
0.840 GeneticVariation GWASCAT Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. 24262325

2014

dbSNP: rs1333049
rs1333049
0.840 GeneticVariation GWASCAT Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. 24262325

2014

dbSNP: rs17465637
rs17465637
0.840 GeneticVariation BEFREE Meta-analysis identifies robust association between SNP rs17465637 in MIA3 on chromosome 1q41 and coronary artery disease. 24125424

2014

dbSNP: rs10455872
rs10455872
LPA
0.840 GeneticVariation BEFREE Extreme lipoprotein(a) levels or corresponding LPA KIV-2/rs10455872 risk genotypes substantially improved MI and CHD risk prediction. 23375930

2013

dbSNP: rs1333049
rs1333049
0.840 GeneticVariation GWASDB A genome-wide association study of a coronary artery disease risk variant. 23364394

2013

dbSNP: rs3798220
rs3798220
LPA
0.840 GeneticVariation BEFREE Using predefined cutpoints for extreme lipoprotein(a) levels and/or corresponding LPA risk genotypes (kringle IV type 2 [KIV-2]) repeat polymorphism, rs3798220, and rs10455872 single nucleotide polymorphisms), we calculated net reclassification indices from <10% to 10% to 19.9% to ≥20% absolute 10-year MI and CHD risk. 23375930

2013

dbSNP: rs10455872
rs10455872
LPA
0.840 GeneticVariation BEFREE For the best SNP rs10455872 for plasma Lp(a) levels, the OR for CHD, CVD, and CVD death was 0.94 (95% CI: 0.69-1.28), 0.97 (0.72-1.29), and 1.23 (0.79-1.92), respectively. 21900290

2012

dbSNP: rs10455872
rs10455872
LPA
0.840 GeneticVariation GWASDB Large-scale gene-centric analysis identifies novel variants for coronary artery disease. 21966275

2012

dbSNP: rs1333049
rs1333049
0.840 GeneticVariation GWASCAT A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. 21606135

2012

dbSNP: rs1333049
rs1333049
0.840 GeneticVariation GWASDB A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. 22319020

2012

dbSNP: rs1333049
rs1333049
0.840 GeneticVariation GWASDB Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. 22751097

2012

dbSNP: rs1333049
rs1333049
0.840 GeneticVariation GWASDB A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. 21606135

2012

dbSNP: rs1333049
rs1333049
0.840 GeneticVariation GWASDB Large-scale gene-centric analysis identifies novel variants for coronary artery disease. 21966275

2012

dbSNP: rs1333049
rs1333049
0.840 GeneticVariation BEFREE To address the relationship of rs1333049, the 9p21 variant showing the strongest association with coronary heart disease (CHD), with carotid plaques and plaque-free common carotid artery intima-media thickness (CCA-IMT) in older adults from 2 French population-based cohorts. 22436605

2012